ATTR Cardiac Amyloidosis in a Selected Population

Recruiting now

Conditions studied: ATTR Amyloidosis Wild Type, ATTR Gene Mutation, Carpal Tunnel Syndrome, Cardiac Amyloidosis

In brief

Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.

Key facts

Study ID

NCT06458374

Run by

Helse Møre og Romsdal HF

People needed

180

Starts

2024-09-01

Expected to finish

2039-02-28

Last updated by the study team

2024-10-16

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male > 50 years
• Female > 60 years
• operated CTS at Ålesund Hospital

You may not qualify if…

• not consented
• do not speak Norwegian
• secondary cause of CTS as traumatic or rheumatic
• cannot be followed > 5 years due to other medical conditions
• Cardiac disease at time of operation for CTS

Where it is running

• Ålesund Hospital — Ålesund, Møre og Romsdal, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.